BIO375H5 Study Guide - Final Guide: Clinical Pharmacology, Blood Substitute, Risk Assessment
Document Summary
Lecture one an overview of biomedical products (questions 1 and 2) Bio375 exam review: synthetic organic molecules (small molecules) made de novo by synthetic chemistry processes or naturally occurring compounds which have been isolated or re-synthesized in the lab. Oligonucleotide based drugs (dna and rna) are also included. Ivd (in vitro diagnostics: devices analyzers for samples like blood, urine, serum, tissue, etc, reagents chemicals used to mark or recognize specific components in the samples. Business models and financial plans vary with the economic or personal context and the goals of the founders. Any business model, to be successful, must come from an understanding of the complete commercialization path for the regulated product. The processes are all carried out in parallel. The business model and the financial plan are equally important: you need to know the economic status to avoid financial problems throughout development and follow through of your business model.
